BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2801828
Number of visits today
766
Number of downloads
2055768
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pallozzi M, Di Tommaso N, Maccauro V, Santopaolo F, Gasbarrini A, Ponziani FR, Pompili M. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022;14:4631. [DOI: 10.3390/cancers14194631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui Z, Wang J, Chen G, Li D, Cheng B, Lai Y, Wu Z. The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression. Front Oncol 2022;12:1081510. [PMID: 36698420 DOI: 10.3389/fonc.2022.1081510] [Reference Citation Analysis]
2 Li S, Wu J, Wu J, Fu Y, Zeng Z, Li Y, Li H, Liao W, Yan M. Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study. Front Immunol 2023;14:1109771. [PMID: 36875116 DOI: 10.3389/fimmu.2023.1109771] [Reference Citation Analysis]
3 Ponziani FR, Giannini EG, Lai Q. Machine learning and biomarkers in hepatocellular carcinoma: The future is now. Liver Cancer International 2022;3:111-112. [DOI: 10.1002/lci2.67] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345